Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 7Urinary Bladder Neoplasms 4Carcinoma, Renal Cell 4Kidney Neoplasms 3Urethral Neoplasms 1Non-Metastatic Prostate Cancer 1Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter 1Locally Advanced Prostate Cancer 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Carcinoma, Transitional Cell 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

tislelizumab 1pamiparib 1TNFeraseBiologic 1Injections 1Gefitinib 1Docetaxel 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Prostate Cancer × Gefitinib × Genitourinary × Clear all
NCT00319787 2011-01-25

Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer

AstraZeneca

Phase 2 Completed
102 enrolled
Genitourinary

Locally Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡